R&D News | pharmaphorum

News

Taiho has reached a deal to buy Swiss biotech Araris, around 18 months after they started collaborating on antibody-drug conjugates for cancer.

News

AbbVie hopes for another lift to its fast-growing ovarian cancer drug Elahere with new survival data.

News

Sutro has shelved its lead drug for ovarian cancer and turned its attention to three preclinical candidates in a major shake-up of its business.

News

Amgen is preparing to file a third indication for Uplizna, as a twice-yearly therapy for generalised myasthenia gravis, following new phase 3 data.

News

Insilico Medicine has raised $110 million in Series E funding for its artificial intelligence-powered drug discovery operations.

News

Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma.